Riggs Asset Managment Co. Inc. Chembio Diagnostics, Inc. Transaction History

Riggs Asset Managment Co. Inc.

  • $335 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023
BUY
$0.2 - $0.33 $265 - $437
1,325 Added 60.92%
3,500 $0
Q3 2022

Nov 08, 2022
BUY
$0.35 - $1.1 $411 - $1,292
1,175 Added 117.5%
2,175 $1,000
Q2 2022

Aug 04, 2022
BUY
$0.45 - $0.8 $450 - $800
1,000 New
1,000 $1,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Riggs Asset Managment Co. Inc. Portfolio

Follow Riggs Asset Managment Co. Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riggs Asset Managment Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Riggs Asset Managment Co. Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email